Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Ocular Drug Delivery Disease Type Market
- 4. Market Overview
- 5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type
- 5.1. Topical
- 5.2. Ocular Insert
- 5.2.1. Erodible
- 5.2.2. Non-Erodible
- 5.3. Iontophoresis
- 5.4. Intraocular Implant
- 5.4.1. Biodegradable
- 5.4.2. Non-Biodegradable
- 5.5. In Situ Gel & Punctal Plug
- 5.6. Others
- 6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type
- 6.1. Solution
- 6.2. Suspension
- 6.3. Emulsion
- 6.4. Liposomes & Nanoparticles
- 6.5. Ointments
- 7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type
- 7.1. Diabetic Retinopathy
- 7.2. Macular Degeneration
- 7.3. Cataract
- 7.4. Glaucoma
- 7.5. Diabetic Macular Edema
- 7.6. Dry Eye Syndrome
- 7.7. Others
- 8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User
- 8.1. Hospitals
- 8.2. Ambulatory Surgical Centers
- 8.3. Ophthalmic Clinics
- 8.4. Homecare Settings
- 9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region
- 9.1. North America
- 9.2. Europe
- 9.3. Asia Pacific
- 9.4. Latin America
- 9.5. Middle East & Africa
- 10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast
- 15. Competition Landscape
- 15.1. OCULAR THERAPEUTIX, INC.
- 15.2. Alimera Sciences
- 15.3. Allergan, Plc
- 15.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
- 15.5. EyeGate Pharma
- 15.6. Envisia Therapeutics
- 15.7. Clearside Biomedical, INC.
- 15.8. Graybug Vision Inc
- 15.9. Santen Pharmaceutical Co., Ltd
- 15.10. Taiwan Liposome Company, Ltd
List of Tables
Table 01: Global Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 02: Global Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 03: Global Market Size (US$ Mn) Forecast, Intraocular Implants, 2022 to 2032
Table 04: Global Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 05: Global Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 06: Global Market Size (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2022 to 2032
Table 08: North America Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 09: North America Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 10: North America Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 11: North America Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 12: North America Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 13: North America Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 14: North America Market Size (US$ Mn) Forecast, by End-user, 2022 to 2032
Table 15: Europe Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 16: Europe Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 17: Europe Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 18: Europe Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 19: Europe Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 20: Europe Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 21: Europe Market Size (US$ Mn) Forecast, by End Users, 2022 to 2032
Table 22: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 23: Asia Pacific Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 24: Asia Pacific Market, by Ocular Inserts, Market Size (US$ Mn) Forecast, 2022 to 2032
Table 25: Asia Pacific Market, by Intraocular Implants, Market Size (US$ Mn) Forecast, 2022 to 2032
Table 26: Asia Pacific Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 27: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 28: Asia Pacific Market Size (US$ Mn) Forecast, by End User, 2022 to 2032
Table 29: Latin America Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 30: Latin America Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 31: Latin America Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 32: Latin America Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 33: Latin America Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 34: Latin America Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 35: Latin America Market Size (US$ Mn) Forecast, by End Users, 2022 to 2032
Table 36: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 37: Middle East & Africa Market Size (US$ Mn) Forecast, by Technology Type, 2022 to 2032
Table 38: Middle East & Africa Market Size (US$ Mn) Forecast, by Ocular Inserts, 2022 to 2032
Table 39: Middle East & Africa Market Size (US$ Mn) Forecast, by Intraocular Implants, 2022 to 2032
Table 40: Middle East & Africa Market Size (US$ Mn) Forecast, by Formulation Type, 2022 to 2032
Table 41: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Type, 2022 to 2032
Table 42: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user, 2022 to 2032
List of Figures
Figure 1: Global Market Size (US$ Mn) Forecast, 2022 to 2032
Figure 2: Global Market Value Share, by Technology Type (2018)
Figure 3: Global Market Value Share, by Formulations Type (2018)
Figure 04: Global Market Value Share, by Disease Type (2018)
Figure 05: Global Market Value Share, by Region (2018)
Figure 06: Global Market Value Share, by End-user (2018)
Figure 07: Global Market Value Share, by Technology Type, 2022 and 2032
Figure 08: Global Market Attractiveness, by Technology Type, 2022 to 2032
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2022 to 2032
Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ocular Inserts, 2022 to 2032
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iontophoresis, 2022 to 2032
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intraocular Implants, 2022 to 2032
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by In Situ Gel & Punctal Plugs, 2022 to 2032
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Technology, 2022 to 2032
Figure 15: Global Market Value Share, by Formulation Type, 2022 and 2032
Figure 16: Global Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Suspension, 2022 to 2032
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Solution, 2022 to 2032
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Liposome & Nanoparticle, 2022 to 2032
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Emulsion, 2022 to 2032
Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ointment, 2022 to 2032
Figure 22: Global Market Value Share, by Disease Type, 2022 and 2032
Figure 23: Global Market Attractiveness, by Disease Type, 2022 to 2032
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Glaucoma, 2022 to 2032
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Retinopathy, 2022 to 2032
Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dry Eye Syndrome, 2022 to 2032
Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Macular Degeneration, 2022 to 2032
Figure 28: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Macular Edema, 2022 to 2032
Figure 29: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cataract, 2022 to 2032
Figure 30: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2022 to 2032
Figure 31: Global Market Value Share, by End-user, 2022 and 2032
Figure 32: Global Market Attractiveness, by End-user, 2022 to 2032
Figure 33: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2022 to 2032
Figure 34: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by ASCs, 2022 to 2032
Figure 35: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ophthalmic Clinics, 2022 to 2032
Figure 36: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care Settings, 2022 to 2032
Figure 37: Global Market Value Share, by Region, 2022 and 2032
Figure 38: Global Market Attractiveness, by Region, 2022 to 2032
Figure 39: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 40: North America Market Value Share, by Country, 2022 and 2032
Figure 41: North America Market Attractiveness, 2022 to 2032
Figure 42: North America Market Value Share, by Technology Type, 2022 and 2032
Figure 43: North America Market Attractiveness, by Technology Type, 2022 to 2032
Figure 44: North America Market Value Share, by Formulation Type, 2022 and 2032
Figure 45: North America Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 46: North America Market Value Share, by Disease Type, 2022 and 2032
Figure 47: North America Market Attractiveness, by Disease Type, 2022 to 2032
Figure 48: North America Market Value Share, by End-user, 2022 and 2032
Figure 49: North America Market Attractiveness, by End-user, 2022 to 2032
Figure 50: Europe Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 51: Europe Market Value Share, by Country, 2022 and 2032
Figure 52: Europe Market Attractiveness, by Country, 2022 to 2032
Figure 53: Europe Market Value Share, by Technology Type, 2022 and 2032
Figure 54: Europe Market Attractiveness, by Technology Type, 2022 to 2032
Figure 55: Europe Market Value Share, by Formulation Type, 2022 and 2032
Figure 56: Europe Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 57: Europe Market Value Share, by Disease Type, 2022 and 2032
Figure 58: Europe Market Attractiveness, by Disease Type, 2022 to 2032
Figure 59: Europe Market Value Share, by End Users, 2022 and 2032
Figure 60: Europe Market Attractiveness, by End Users, 2022 to 2032
Figure 61: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022 to 2032
Figure 62: Asia Pacific Market Value Share, by Country, 2022 and 2032
Figure 63: Asia Pacific Market Attractiveness, by Country, 2022 to 2032
Figure 64: Asia Pacific Market Value Share, by Technology Type, 2022 and 2032
Figure 65: Asia Pacific Market Attractiveness, by Technology Type, 2022 to 2032
Figure 66: Asia Pacific Market Value Share, by Formulation Type, 2022 and 2032
Figure 67: Asia Pacific Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 68: Asia Pacific Market Value Share, by Disease Type, 2022 and 2032
Figure 69: Asia Pacific Market Attractiveness, by Disease Type, 2022 to 2032
Figure 70: Asia Pacific Market Value Share, by End User, 2022 and 2032
Figure 71: Asia Pacific Market Attractiveness, by End User, 2022 to 2032
Figure 72: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022 to 2032
Figure 73: Latin America Market Value Share, by Country, 2022 and 2032
Figure 74: Latin America Market Attractiveness, by Country, 2022 to 2032
Figure 75: Latin America Market Value Share, by Technology Type, 2022 and 2032
Figure 76: Latin America Market Attractiveness, by Technology Type, 2022 to 2032
Figure 77: Latin America Market Value Share, by Formulation Type, 2022 and 2032
Figure 78: Latin America Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 79: Latin America Market Value Share, by Disease Type, 2022 and 2032
Figure 80: Latin America Market Attractiveness, by Disease Type, 2022 to 2032
Figure 81: Latin America Market Value Share, by End Users, 2022 and 2032
Figure 82: Latin America Market Attractiveness, by End Users, 2022 to 2032
Figure 83: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2022 to 2032
Figure 84: Middle East & Africa Market Value Share, by Country, 2022 and 2032
Figure 85: Middle East & Africa Market Attractiveness, by Country, 2022 to 2032
Figure 86: Middle East & Africa Market Value Share, by Technology Type, 2022 and 2032
Figure 87: Middle East & Africa Market Attractiveness, by Technology Type, 2022 to 2032
Figure 88: Middle East & Africa Market Value Share, by Formulation Type, 2022 and 2032
Figure 89: Middle East & Africa Market Attractiveness, by Formulation Type, 2022 to 2032
Figure 90: Middle East & Africa Market Value Share, by Disease Type, 2022 and 2032
Figure 91: Middle East & Africa Market Attractiveness, by Disease Type, 2022 to 2032
Figure 92: Middle East & Africa Market Value Share, by End-user, 2022 and 2032
Figure 93: Middle East & Africa Market Attractiveness, by End-user, 2022 to 2032
Figure 94: Global Market Share, by Company, 2021
